Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pragmatic, Double-blind, Placebo-controlled Randomized Clinical Trial, Evaluating Hydroxychloroquine for Prevention of Hospitalization and Respiratory Complications in Non-hospitalized Patients With Confirmed or Probable COVID-19

NCT04466540 is registered in ClinicalTrials.gov with Hospital Alemão Oswaldo Cruz as lead sponsor.

NCT NCT04466540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04466540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pragmatic, Double-blind, Placebo-controlled Randomized Clinical Trial, Evaluating Hydroxychloroquine for Prevention of Hospitalization and Respiratory Complications in Non-hospitalized Patients With Confirmed or Probable COVID-19
Lead sponsor
Hospital Alemão Oswaldo Cruz
Phase
Phase 4
Overall status
Completed
Start date
May 12, 2020
Completion date
September 28, 2021
Enrollment
1,372 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19